Entry Detail



General Information

Database ID:exR0000087
RNA Name:ABHD4
RNA Type:mRNA
Chromosome:chr14
Starnd:+
Coordinate:
Start Site(bp):22598237End Site(bp):22613215
External Links:ENSG00000100439



Disease Information

Disease Name:Down Syndrome
Disease Category:Congenital, Hereditary, and Neonatal Diseases and Abnormalities
MeSH ID:D004314
Type:Diseases Category/Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Alias:Syndrome, Down//Mongolism//47,XY,+21//Trisomy G//47,XX,+21//Down's Syndrome//Downs Syndrome//Syndrome, Down's//Trisomy 21//Trisomy 21, Mitotic Nondisjunction//Down Syndrome, Partial Trisomy 21//Partial Trisomy 21 Down Syndrome//Trisomy 21, Meiotic Nondisjunction



Expression Detail

GEO ID:GSE16176
Description:Expression profiles of amniotic fluid from human fetuses with Down syndrome and euploid controls
Experimental Design:Disease vs Control
Case Disease Type:Down Syndrome
Case Disease SubType:NA
Case Sample:Down Syndrome
Control Sample:Normal
Number of Case:7
Number of Control:7
Number of Samples:14





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
FAM219A
chr9
34398184
34458570
-
RPL32
chr3
12834485
12841582
-
ZNF708
chr19
21291160
21329425
-
AP2A1
chr19
49766968
49807113
+
ARHGEF4
chr2
130836916
131047263
+
POLD4
chr11
67350772
67356972
-
PITPNC1
chr17
67377281
67697261
+
TUBA1A
chr12
49184795
49189080
-
TRIP6
chr7
100867387
100873454
+
AXIN1
chr16
287440
352723
-
HAT1
chr2
171922448
171983686
+
MYL12A
chr18
3247481
3256236
+
HNRNPA1
chr12
54280193
54287088
+
PSMB8
chr6
32840717
32844679
-
MT-CO1
chrMT
5904
7445
+
GAPDH
chr12
6534512
6538374
+
CNPPD1
chr2
219171897
219178106
-
DDX1
chr2
15591178
15631111
+
HNRNPK
chr9
83968083
83980616
-
OGT
chrX
71533104
71575892
+
PUM1
chr1
30931506
31065991
-
BTBD2
chr19
1985438
2034881
-
PSAP
chr10
71816298
71851325
-
EWSR1
chr22
29268009
29300525
+
EIF6
chr20
35278911
35284985
-
KDM5B
chr1
202724495
202808487
-
CBSL
chr21
6444869
6468040
-
AL121753.1
chr20
35267885
35280043
-
CCT8
chr21
29055805
29073797
-
TRPV3
chr17
3510502
3557995
-
miRNA targets:
miRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa-miR-31-5p
chr9
21512158
21512178
-
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AGAP1-IT1
chr2
235505751
235507566
+
GATA2-AS1
chr3
128489212
128502970
+
Display:



Experiment Detail

GEO ID:GSE16176
Sample Source:Amniotic Fluid
Source Fraction:Supernatant
Platform:GPL570
Method:Microarray
Num of detected RNA Type:1
Num of detected RNAs of this Type:17063
Sample treatment protocol:NA
RNA Extract protocol:RNA was extracted from 10 mL AF with 30 mL TRIzol LS Reagent (Invitrogen, Carlsbad, CA) and 8 mL chloroform. After RNA extraction, RNA was purified and DNA was removed using the RNeasy® Maxi Kit, including the DNase step according to the manufacturer's protocol (QIAGEN, Valencia, CA). RNA was precipitated using 3M NaOAc and 100% ethanol, and 80% ethanol was added after 4 hours incubation at -20 °C. cDNA, synthesized from extracted RNA, was amplified and purified using the WT-Ovation™ Pico RNA Amplification System (NuGEN, San Carlos, CA) and the DNA Clean & Concentrator™-25 (Zymo Research, Orange, CA).
RNA library preparation protocol:biotin Samples were labeled using the FL-Ovation™ cDNA Biotin Module V2 (NuGEN, San Carlos, CA).



Reference

PMID:19474297
Title:Functional genomic analysis of amniotic fluid cell-free mRNA suggests that oxidative stress is significant in Down syndrome fetuses
Author:Slonim DK, Koide K, Johnson KL, Tantravahi U, Cowan JM, Jarrah Z, Bianchi DW
Journal:Proc Natl Acad Sci U S A. 2009 Jun 9;106(23):9425-9.
Description:To characterize the differences between second trimester Down syndrome (DS) and euploid fetuses, we used Affymetrix microarrays to compare gene expression in uncultured amniotic fluid supernatant samples.